Cancer Causes & Control

, Volume 18, Issue 8, pp 839–845 | Cite as

Urinary tract diseases and bladder cancer risk: a case–control study

  • Manisha Jhamb
  • Jie Lin
  • Rebecca Ballow
  • Ashish M. Kamat
  • H. Barton Grossman
  • Xifeng Wu
Original Paper



The role of urinary tract diseases in bladder cancer (BC) etiology is not well established. To gain more insight on the role of urinary tract diseases in bladder cancer risk, we analyzed data from a large case–control study of bladder cancer.


Epidemiological data were collected via in-person interview. Logistic regression analyses were used to estimate BC risk in association with prior history of urinary tract diseases.


A total of 659 BC patients and 689 age-, gender-, -ethnicity matched controls were included in the analyses. Increased bladder cancer risk was associated with history of cystitis (OR = 1.52, 95% CI: 1.12, 2.06), however, the risk was attenuated for infections diagnosed >1 year from the time of BC diagnosis or interview. In contrast, a history of four or more kidney infections was associated with a significant decreased risk of BC (OR=0.17, 95% CI: 0.04, 0.69), and there was a significant dose-response relationship between number of episode and BC risk (P for trend = 0.002). The joint effect of smoking with cystitis, kidney infection, bladder stone, kidney stone, and prostate infection was studied but revealed no significant interaction between smoking and these urinary tract diseases.


This study does not support the concept that urinary tract infections play a major role in the development of BC. Our study has the strength of collecting diagnosis time data of urinary tract diseases to allow analyzing the impact of timing of diagnosis between cancer and urinary tract diseases. This enables us to effectively address the issue of detection bias in case–controls studies of prior urinary diseases and BC.


Bladder cancer Urinary tract diseases Case–control study 



This study was supported by the following grants: CA 74880 and CA 91846


  1. 1.
    American Cancer Society. Cancer Facts and Figures 2006. Available at
  2. 2.
    Kirkali Z, Chan T, Manoharan M et al (2005) Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 66:4–34PubMedCrossRefGoogle Scholar
  3. 3.
    Taioli E, Raimondi S (2005) Genetic susceptibility to bladder cancer. Lancet 366:610–612PubMedCrossRefGoogle Scholar
  4. 4.
    Wu X, Gu J, Grossman HB et al (2006) Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet 78:464–479PubMedCrossRefGoogle Scholar
  5. 5.
    Castellsagué X, Díaz M, de Sanjosé S et al (2006) Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst 98:303–315PubMedCrossRefGoogle Scholar
  6. 6.
    Forman D (1998) Helicobacter pylori: the gastric cancer problem. Gut 43:S33–S34PubMedCrossRefGoogle Scholar
  7. 7.
    Tsukuma H, Tanaka H, Ajiki W et al (2005) Liver cancer and its prevention. Asian Pac J Cancer Prev 6:244–250PubMedGoogle Scholar
  8. 8.
    González CA, Errezola M, Izarzugaza I et al (1991) Urinary infection, renal lithiasis and bladder cancer in spain. Eur J Cancer 27:498–500PubMedCrossRefGoogle Scholar
  9. 9.
    Kantor AF, Hartge P, Hoover RN et al (1984) Urinary tract infection and risk of bladder cancer. Am J Epidemiol 119:510–515PubMedGoogle Scholar
  10. 10.
    Kjaer SK, Knudsen JB, Sørensen BL et al (1989) The copenhagen case–control study of bladder cancer. V. review of the role of urinary-tract infection. Acta Oncol 28:631–636PubMedGoogle Scholar
  11. 11.
    La Vecchia C, Negri E, D’Avanzo B et al (1991) Genital and urinary tract diseases and bladder cancer. Cancer Res 51:629–631PubMedGoogle Scholar
  12. 12.
    Khurana S, Dubey ML, Malla N (2005) Association of parasitic infections and cancers. Indian J Med Microbiol 23:74–79PubMedCrossRefGoogle Scholar
  13. 13.
    Hess MJ, Zhan EH, Foo DK et al (2003) Bladder cancer in patients with spinal cord injury. J Spinal Cord Med 26:335–338PubMedGoogle Scholar
  14. 14.
    Kaufman JM, Fam B, Jacobs SC et al (1997) Bladder cancer and squamous metaplasia in spinal cord injury patients. J Urol 118:967–971Google Scholar
  15. 15.
    van Velzen D, Krishnan KR, Parsons KF et al (1995) Comparative pathology of dome and trigone of urinary bladder mucosa in paraplegics and tetraplegics. Paraplegia 33:565–572PubMedGoogle Scholar
  16. 16.
    Kunze E, Chang-Claude J, Frentzel-Beyme R (1992) Life style and occupational risk factors for bladder cancer in germany. A case–control study. Cancer 69:1776–1790PubMedCrossRefGoogle Scholar
  17. 17.
    Piper JM, Matanoski GM, Tonascia J (1986) Bladder cancer in young women. Am J Epidemiol 123:1033–1042PubMedGoogle Scholar
  18. 18.
    Dunham LJ, Rabson AS, Stewart HL et al (1968) Rates, interview, and pathology study of cancer of the urinary bladder in New Orleans, Louisiana. J Natl Cancer Inst 41:683–709PubMedGoogle Scholar
  19. 19.
    Wynder EL, Onderdonk J, Mantel N (1963) An epidemiological investigation of cancer of the bladder. Cancer 16:1388–1407PubMedCrossRefGoogle Scholar
  20. 20.
    Hudmon KS, Honn SE, Jiang H et al (1997) Identifying and recruiting healthy control subjects from a managed care organization: a methodology for molecular epidemiological case–control studies of cancer. Cancer Epidemiol Biomarkers Prev 6:565–571PubMedGoogle Scholar
  21. 21.
    Howe GR, Burch JD, Miller AB et al (1980) Tobacco use, occupation, coffee, various nutrients, and bladder cancer. J Natl Cancer Inst 64:701–713PubMedGoogle Scholar
  22. 22.
    Chow WH, Lindblad P, Gridley G et al (1997) Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst 89:1453–1457PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media B.V. 2007

Authors and Affiliations

  • Manisha Jhamb
    • 1
  • Jie Lin
    • 1
  • Rebecca Ballow
    • 1
  • Ashish M. Kamat
    • 2
  • H. Barton Grossman
    • 2
  • Xifeng Wu
    • 1
  1. 1.Department of Epidemiology, Unit 1340The University of Texas M.D. Anderson Cancer CenterHoustonUSA
  2. 2.Department of UrologyThe University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations